Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
NCT ID: NCT00365911
Last Updated: 2011-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2000 participants
INTERVENTIONAL
2006-03-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The medical file is gathered. There will be searched for an association between renal function and cardiovascular risk factors and risk factors by exposition to toxic substantia during work.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of Serum Creatinine Dosage and Renal Clearance
NCT00323128
Evaluation of the Renal Function in an Ultra-endurance Race.
NCT03136315
Arterial Stiffness, Wave Reflections and Renal Failure
NCT00354588
Screening for Albuminuria at the First Line for Early Identification of CKD
NCT05321095
Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry
NCT03314363
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Taking blood sample
A blood sample will be taken.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and female subjects
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prevemed-Medibo
UNKNOWN
Medical Laboratory CRI
UNKNOWN
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Ghent
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raymond Vanholder, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Ghent
Wim Van Biesen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ghent
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
van der Tol A, Van Biesen W, Verbeke F, De Groote G, Vermeiren F, Eeckhaut K, Vanholder R. Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial. PLoS One. 2010 Oct 13;5(10):e13328. doi: 10.1371/journal.pone.0013328.
Related Links
Access external resources that provide additional context or updates about the study.
Website University Hospital Ghent
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006/038
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.